Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
6.99
0.00 (0.00%)
Jun 27, 2025, 10:59 AM - Market open
Exagen Employees
As of December 31, 2024, Exagen had 215 total employees, including 209 full-time and 6 part-time employees. The number of employees increased by 36 or 20.11% compared to the previous year.
Employees
215
Change (1Y)
36
Growth (1Y)
20.11%
Revenue / Employee
$263,833
Profits / Employee
-$72,126
Market Cap
152.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XGN News
- 4 days ago - Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics - GlobeNewsWire
- 6 weeks ago - Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares - GlobeNewsWire
- 7 weeks ago - Exagen Inc. Prices Public Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Exagen Inc. Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Exagen Inc. (XGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume - GlobeNewsWire
- 2 months ago - Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors - GlobeNewsWire
- 2 months ago - Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability - Seeking Alpha